Oruka Therapeutics (ORKA) EBITDA (2010 - 2024)
Oruka Therapeutics' EBITDA came in at -$3.12 million for Q2 2024, compared with -$1.97 million a year earlier.
Powered by 
Analysis
Oruka Therapeutics (ORKA) EBITDA (2010 - 2024) Analysis & Trends
Over the trailing twelve months to Jun 30, 2024, Oruka Therapeutics reported EBITDA of -$9.12 million; for FY2023, it was -$7.28 million.
- Going back by year, EBITDA was -$10.58 million in FY2022, -$19.32 million in FY2021, -$9.76 million in FY2020 and -$5.8 million in FY2019.
- The Q2 2024 figure represents the lowest quarterly EBITDA since Q2 2022.
- Business Quant data shows ORKA's EBITDA at -$2.48 million (Q1 2024), -$1.59 million (Q4 2023) and -$1.93 million (Q3 2023) in the three quarters before Q2 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 9.10 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 8.33 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 999.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 5.09 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 4.63 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -9.70 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 5.89 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 1.30 Bn |
| 10 | Oruka Therapeutics | 5.29 Bn | 3.34 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2024 | -3.12 Mn |
| Mar 31, 2024 | -2.48 Mn |
| Dec 31, 2023 | -1.59 Mn |
| Sep 30, 2023 | -1.93 Mn |
| Jun 30, 2023 | -1.97 Mn |
| Mar 31, 2023 | -1.79 Mn |
| Dec 31, 2022 | -1.54 Mn |
| Sep 30, 2022 | -2.55 Mn |
| Jun 30, 2022 | -3.21 Mn |
| Mar 31, 2022 | -3.27 Mn |
| Dec 31, 2021 | -5.68 Mn |
| Sep 30, 2021 | -4.71 Mn |
| Jun 30, 2021 | -4.83 Mn |
| Mar 31, 2021 | -4.10 Mn |
| Dec 31, 2020 | -5.12 Mn |
| Sep 30, 2020 | -1.99 Mn |
| Jun 30, 2020 | -1.31 Mn |
| Mar 31, 2020 | -1.34 Mn |
| Dec 31, 2019 | -1.28 Mn |
| Sep 30, 2019 | -1.24 Mn |
API Access
Oruka Therapeutics EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=ORKA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "ORKA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=ORKA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();